Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Valerio, Felipe
STAR, NCT04053283: First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector	Active, not recruiting	1	186	US	NG-641	Akamis Bio	Metastatic Cancer, Epithelial Tumor	08/24	12/24
NEBULA, NCT05043714: Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours Initiation of trial in combination with NG-641 Sep 2021 - Sep 2021: Initiation of trial in combination with NG-641	Active, not recruiting	1	30	Europe, US	NG-641 in combination with Nivolumab	Akamis Bio, Bristol-Myers Squibb	Metastatic Cancer, Epithelial Tumor	08/24	12/24
Candelaria, Lesbia
No trials found